Figure 1. RPPH1 is expressed in AML tissues and cell lines and its high expression predicts worse overall survival of AML patients. (A) Relative expression level of RPPH1 in the PBMCs from healthy control donors (Control) and AML patients (AML) was determined by RT-qPCR. (B) Relative expression level of RPPH1 in human bone marrow stromal cell line HS-5 and three human AML cell lines (THP-1, HL-60 and KG-1) was determined by RT-qPCR. (C) Overall survival analysis by Kaplan-Meier and log-rank test indicated that the AML patients with higher RPPH1 level had worse outcome compared with those with lower RPPH1 level. **P<0.01, compared with the indicated controls.
